Mount Sinai genomics spinoff Sema4 let go of 250 employees, bringing the company's 2022 workforce reduction to 30%, in today's bite-sized hospital and health industry news from Connecticut, Florida, and South Carolina.

• Connecticut: Sema4 laid off 13% of its workforce as part of an initiative to save $50 million this year, bringing the company's total 2022 workforce reduction to 30%. Along with the 250 employees, Sema4 founder Eric Schadt on Monday departed. Matthew Davis, who previously worked for genetic testing company Invitae, will take over as Sema4's chief technology and product officer. At the end of 2022, the company also plans to exit the somatic tumor-testing business and close one of its clinical laboratories. "As we look forward, Sema4 will have a dramatically improved cost structure and a more targeted commercial effort supported by an optimized product development strategy," said Sema4 CEO Katherine Stueland. "This will enable us to continue to accelerate the use of genomics and leverage clinical data to enhance the standard of care through the more extensive use of precision medicine." (Bruce, Becker's Hospital Review, 8/16)

• Florida: HCA Florida Palms West Hospital named Cheryl Wild as its new CNO. Wild, who started her career as a certified nursing assistant, has served in medical-surgical units and open-heart ICUs throughout her career. In addition, she previously served as the CNO of Broward Health in Fort Lauderdale. In her new role, Wild will oversee the recruiting and hiring of nurses to the patient care team. (Carbajal, Becker's Hospital Review, 8/12)

• South Carolina: Aiken Regional Medical Centers on Monday appointed Matthew Merrifield as its new CEO. Merrifield, who brings over 12 years of health care leadership experience to the role, previously served as COO of Summerlin Hospital Medical Center in Las Vegas and COO of Aiken Regional. He succeeds Jim O'Loughlin, who will retire from Aiken Regional next month. (Gooch, Becker's Hospital Review, 8/16)